|Bid||233.50 x 1200|
|Ask||406.88 x 800|
|Day's Range||253.27 - 260.49|
|52 Week Range||235.01 - 405.90|
|Beta (5Y Monthly)||1.16|
|PE Ratio (TTM)||27.76|
|Earnings Date||Apr 27, 2022 - May 02, 2022|
|Forward Dividend & Yield||1.36 (0.57%)|
|Ex-Dividend Date||Aug 12, 2022|
|1y Target Est||315.18|
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
For UroLift, Teleflex (TFX) witnesses revenue declines in all sites of service, including hospital, ASC and physician's office.
WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access products from Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company. The agreement is effective starting August 1, 2022. Vizient provides solutions and services that improve the delivery of high-value care by aligning cost, quality, and market performance for m